48 related articles for article (PubMed ID: 9517922)
21. Characterization of a beta-lactamase from Clostridium clostridioforme.
Appelbaum PC; Spangler SK; Pankuch GA; Philippon A; Jacobs MR; Shiman R; Goldstein EJ; Citron DM
J Antimicrob Chemother; 1994 Jan; 33(1):33-40. PubMed ID: 8157571
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo antibacterial activities of MT-141, a new semisynthetic cephamycin, compared with those of five cephalosporins.
Inouye S; Goi H; Watanabe T; Hara T; Miyauchi K; Yoshida T; Kazuno Y; Kadosawa H; Hirano F; Kawaharajo K
Antimicrob Agents Chemother; 1984 Nov; 26(5):722-9. PubMed ID: 6440478
[TBL] [Abstract][Full Text] [Related]
23. In-vitro activity of cefotiam against bacteria of clinical interest.
Watt B; Brown FV
J Antimicrob Chemother; 1982 Nov; 10(5):391-5. PubMed ID: 6294043
[No Abstract] [Full Text] [Related]
24. Comparative bactericidal and morphological effects of five cephamycins on cells of three gram-negative bacilli at decreasing drug concentrations.
Goi H; Watanabe T; Miyauchi K; Kazuno Y; Inouye S
Drugs Exp Clin Res; 1985; 11(11):771-80. PubMed ID: 3915467
[TBL] [Abstract][Full Text] [Related]
25. Antibacterial activity of cefminox against anaerobes.
Watanabe K; Sawa K; Bunai M; Ueno K
J Antibiot (Tokyo); 1985 May; 38(5):649-60. PubMed ID: 3874857
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of beta-lactam resistance in anaerobic bacteria.
Nord CE
Rev Infect Dis; 1986; 8 Suppl 5():S543-8. PubMed ID: 3541135
[TBL] [Abstract][Full Text] [Related]
27. Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes.
Appelbaum PC; Jacobs MR; Spangler SK; Yamabe S
Antimicrob Agents Chemother; 1986 Nov; 30(5):789-91. PubMed ID: 3026241
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of cephem antibiotics in exudate of pelvic retroperitoneal space after radical hysterectomy and pelvic lymphadenectomy.
Ito K; Hayasaki M; Tamaya T
Antimicrob Agents Chemother; 1990 Jun; 34(6):1160-4. PubMed ID: 2393276
[TBL] [Abstract][Full Text] [Related]
29. Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology.
Aldridge KE; Wexler HM; Sanders CV; Finegold SM
Antimicrob Agents Chemother; 1990 Jan; 34(1):179-81. PubMed ID: 2327757
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of two methods for rapid testing for beta-lactamase production in Bacteroides and Fusobacterium.
Appelbaum PC; Spangler SK; Jacobs MR
Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):47-50. PubMed ID: 2303067
[TBL] [Abstract][Full Text] [Related]
31. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
32. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Appelbaum PC; Spangler SK; Jacobs MR
Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of cefminox in the treatment of bacterial infections.
Omoto S; Watanabe S
Int J Clin Pharmacol Res; 1990; 10(6):361-8. PubMed ID: 2099361
[TBL] [Abstract][Full Text] [Related]
34. Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance.
Appelbaum PC; Philippon A; Jacobs MR; Spangler SK; Gutmann L
Antimicrob Agents Chemother; 1990 Nov; 34(11):2169-76. PubMed ID: 2073107
[TBL] [Abstract][Full Text] [Related]
35. Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.
Appelbaum PC; Spangler SK; Jacobs MR
Antimicrob Agents Chemother; 1991 Jun; 35(6):1214-8. PubMed ID: 1929264
[TBL] [Abstract][Full Text] [Related]
36. Comparative susceptibility of cefminox and cefoxitin to beta-lactamases of Bacteroides spp.
Soriano F; Edwards R; Greenwood D
J Antimicrob Chemother; 1991 Jul; 28(1):55-60. PubMed ID: 1769943
[TBL] [Abstract][Full Text] [Related]
37. Effect of inoculum size on bacteriolytic activity of cefminox and four other beta-lactam antibiotics against Escherichia coli.
Soriano F; Edwards R; Greenwood D
Antimicrob Agents Chemother; 1992 Jan; 36(1):223-6. PubMed ID: 1590693
[TBL] [Abstract][Full Text] [Related]
38. Cloning of a Bacteroides fragilis chromosomal determinant coding for 5-nitroimidazole resistance.
Haggoud A; Reysset G; Sebald M
FEMS Microbiol Lett; 1992 Aug; 74(1):1-5. PubMed ID: 1516803
[TBL] [Abstract][Full Text] [Related]
39. Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin.
Appelbaum PC; Spangler SK; Shiman R; Jacobs MR
Antimicrob Agents Chemother; 1992 May; 36(5):1140-3. PubMed ID: 1324639
[TBL] [Abstract][Full Text] [Related]
40. In vitro activities of cefminox against anaerobic bacteria compared with those of nine other compounds.
Hoellman DB; Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Mar; 42(3):495-501. PubMed ID: 9517922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
